Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376

Ionic dependence of glutamate neurotoxicity

Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703

Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures

Lovell, M. A., Xie, C., & Markesbery, W. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00346-4 · Cited by 127

Alzheimer’s amyloid β-peptide (1–42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide

Butterfield, D. A., & Bush, A. I. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.027 · Cited by 129

The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis

Prow, N. A., & Irani, D. N. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05230.x · Cited by 126

Diversity of astroglial responses across human neurodegenerative disorders and brain aging

Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 135

Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals

Honer, W. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.005 · Cited by 135

Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane

Zoladz, P. R., CAMPBELL, A., Park, C. R., Schaefer, D., Danysz, W., & Diamond, D. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.08.011 · Cited by 122

Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice

Sompol, P., Furman, J. L., Pleiss, M. M., Kraner, S. D., Artiushin, I. A., Batten, S. R., Quintero, J. E., Simmerman, L. A., Beckett, T. L., Lovell, M. A., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0877-17.2017 · Cited by 123

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E., Dugas, J., Pizzo, M. E., DeVos, S. L., Earr, T. K., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00547-7 · Cited by 124

Dendritic and Synaptic Pathology in Experimental Autoimmune Encephalomyelitis

Zhu, B., Luo, L., Moore, G. R. W., Paty, D. W., & Cynader, M. S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64298-8 · Cited by 119

nNOS Expressing Neurons in the Entorhinal Cortex and Hippocampus Are Affected in Patients with Alzheimer's Disease

Thorns, V., Hansen, L., & Masliah, E. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6751 · Cited by 119

Regulation of glutamate transporters in health and disease

Gegelashvili, G., Robinson, M. B., Trotti, D., & Rauen, T. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32082-4 · Cited by 119

Excitatory-inhibitory imbalance in Alzheimer's disease and therapeutic significance

Varela, E. V., Etter, G., & Williams, S. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.04.010 · Cited by 122

Contribution of astrocytes to neuropathology of neurodegenerative diseases

Acıoğlu, Ç., Li, L., & Elkabes, S. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147291 · Cited by 119

Age and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole

Pereira, A. C., Gray, J. D., Kogan, J. F., Davidson, R. L., Rubin, T. G., Okamoto, M., Morrison, J. H., & McEwen, B. S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.33 · Cited by 116

Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome

Lockrow, J. P., Boger, H. A., Bimonte‐Nelson, H. A., & Granholm, A. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.036 · Cited by 118

SLC1 glutamate transporters

Grewer, C. T., Gameiro, A. M., & Rauen, T. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1397-7 · Cited by 115

Viral-Induced Spinal Motor Neuron Death Is Non-Cell-Autonomous and Involves Glutamate Excitotoxicity

Darman, J., Backovic, S., Dike, S., Maragakis, N. J., Krishnan, C., Rothstein, J. D., Irani, D. N., & Kerr, D. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2002-04.2004 · Cited by 115

When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease

Avila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114

Chapter 3 Properties and localization of glutamate transporters

Danbolt, N. C., Chaudhry, F. A., Dehnes, Y., Lehre, K. P., Levy, L. M., Ullensvang, K., & Storm‐Mathisen, J. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60428-8 · Cited by 112

Expression of the glutamate transporters in human temporal lobe epilepsy

Tessler, S., Danbolt, N. C., Faull, R. L. M., Storm‐Mathisen, J., & Emson, P. C. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00301-7 · Cited by 112

The interactions of genes, age, and environment in glaucoma pathogenesis

Doucette, L. P., Rasnitsyn, A., Seifi, M., & Walter, M. A. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.01.004 · Cited by 114

Beneficial Effects of Dietary Restriction on Cerebral Cortical Synaptic Terminals

Guo, Z., Ersöz, A., Butterfield, D. A., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750314.x · Cited by 110

Region- and Age-Specific Changes in Glutamate Transport in the AβPP23 Mouse Model for Alzheimer's Disease

Schallier, A., Smolders, I., Van Dam, D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., & Massie, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101005 · Cited by 109

Don’t get too excited: mechanisms of glutamate-mediated Purkinje cell death

Slemmer, J. E., De Zeeuw, C. I., & Weber, J. T. (2005) · Progress in Brain Research · doi:10.1016/s0079-6123(04)48029-7 · Cited by 108

Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism

Jhala, S. S., & Hazell, A. S. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.11.019 · Cited by 109

Astroglia as a cellular target for neuroprotection and treatment of neuro‐psychiatric disorders

Liu, B., Teschemacher, A. G., & Kasparov, S. (2017) · Glia · doi:10.1002/glia.23136 · Cited by 111

Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody

Shashidharan, P., Huntley, G. W., Murray, J., Buku, A., Moran, T. M., Walsh, M. J., Morrison, J. H., & Plaitakis, A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00921-9 · Cited by 107

Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease

Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105

Alzheimer’s Disease: Mechanism and Approach to Cell Therapy

Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 110

Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis

Hölscher, C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0193 · Cited by 106

Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease

Nanclares, C., Baraibar, A. M., Araque, A., & Kofuji, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157887 · Cited by 103

The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?

Kurkinen, M. T., Fułek, M., Fułek, K., Beszłej, J. A., Kurpas, D., & Leszek, J. (2023) · Biomolecules · doi:10.3390/biom13030453 · Cited by 105

Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): Implications for Alzheimer’s Disease

Boyd-Kimball, D., Poon, H. F., Lynn, B. C., Cai, J., Pierce Jr., W. M., Klein, J. B., Ferguson, J., Link, C. D., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.001 · Cited by 98

Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain

Kobayashi, E., Nakano, M., Kubota, K., Himuro, N., Mizoguchi, S., Chikenji, T., Otani, M., Mizue, Y., Nagaishi, K., & Fujimiya, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-19442-7 · Cited by 98

Synaptic plasticity in Alzheimer’s disease and healthy aging

Torres, D. M. C., & Cárdenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 101

Cortical Cholinergic Dysfunction After Human Head Injury

MURDOCH, I., PERRY, E. K., COURT, J. A., GRAHAM, D. I., & DEWAR, D. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.295 · Cited by 121

Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease

Robinson, S. R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10057 · Cited by 96

Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease

Beckstrøm, H., Julsrud, L., Haugeto, Ø., Dewar, D., Graham, D. I., Lehre, K. P., Storm‐Mathisen, J., & Danbolt, N. C. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990115)55:2 · Cited by 96

Tau-mediated synaptic damage in Alzheimer’s disease

Jadhav, S., Cubinkova, V., Zimova, I., Brezováková, V., Maďari, A., Cigánková, V., & Žilka, N. (2015) · Translational Neuroscience · doi:10.1515/tnsci-2015-0023 · Cited by 97

Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide

Casley, C. S., Lakics, V., Lee, H., Broad, L. M., Day, T. A., Cluett, T., Smith, M. A., O’Neill, M. J., & Kingston, A. E. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.082 · Cited by 98

Early network dysfunction in Alzheimer's disease

Selkoe, D. J. (2019) · Science · doi:10.1126/science.aay5188 · Cited by 95

Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer’s molecular signatures

Sharma, A., Kazim, S. F., Larson, C. S., Ramakrishnan, A., Gray, J. D., McEwen, B. S., Rosenberg, P. A., Shen, L., & Pereira, A. C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903566116 · Cited by 92

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease

Hector, A., & Brouillette, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.600084 · Cited by 97

Local Injection of Antisense Oligonucleotides Targeted to the Glial Glutamate Transporter GLAST Decreases the Metabolic Response to Somatosensory Activation

Cholet, N., Pellerin, L., Welker, E., Lacombe, P. M., Seylaz, J., Magistretti, P. J., & Bonvento, G. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200104000-00009 · Cited by 90

Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease

Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85

The Effects of Acupuncture on Glutamatergic Neurotransmission in Depression, Anxiety, Schizophrenia, and Alzheimer's Disease: A Review of the Literature

Tu, C., MacDonald, I. J., & Chen, Y. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00014 · Cited by 90

Glial Glutamine Homeostasis in Health and Disease

Andersen, J. V., & Schousboe, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03771-1 · Cited by 92

Increased expression of cholesterol 24S‐hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer’s disease

Tian, G., Kong, Q., Lai, L., Ray‐Chaudhury, A., & Lin, C. G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06661.x · Cited by 87

Transcranial magnetic stimulation in Alzheimer’s disease: a neurophysiological marker of cortical hyperexcitability

Pennisi, G., Ferri, R., Lanza, G., Cantone, M., Pennisi, M., Puglisi, V., Malaguarnera, G., & Bella, R. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0554-9 · Cited by 85

Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease

Zoia, C., Cogliati, T., Tagliabue, E., Cavaletti, G., Sala, G., Galimberti, G., Rivolta, I., Rossi, V., Frattola, L., & Ferrarese, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00085-x · Cited by 85

Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function

Zhong, N., Ramaswamy, G., & Weisgraber, K. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014464 · Cited by 87

Translational Control of Glial Glutamate Transporter EAAT2 Expression

Tian, G., Lai, L., Guo, H., Lin, Y., Butchbach, M. E. R., Chang, Y., & Lin, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609822200 · Cited by 85

The role of excitotoxicity in ALS - what is the evidence?

Ludolph, A. C., Meyer, T., & Riepe, M. W. (2000) · Journal of Neurology · doi:10.1007/s004150050552 · Cited by 84

Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases

Sompol, P. M., & Norris, C. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00199 · Cited by 84

Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies

Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 83

β-Amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism

Fernández-Tomé, P., Brera, B., Arévalo, M., & CEBALLOS, M. L. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.006 · Cited by 85

The dual face of glutamate: from a neurotoxin to a potential survival factor—metabolic implications in health and disease

Magi, S., Piccirillo, S., & Amoroso, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-3002-x · Cited by 79

Activated astrocytes: a therapeutic target in Alzheimer’s disease?

Fuller, S. L., Münch, G. W., & Steele, M. L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.111 · Cited by 77

Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes

Amir, R. E., den Veyver, I. B. V., Schultz, R., Malicki, D. M., Tran, C. Q., Dahle, E. J., Philippi, A., Tímár, L., Percy, A. K., Motil, K. J., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5 · Cited by 351

Epilepsy and Alzheimer’s Disease: Potential mechanisms for an association

Giorgi, F. S., Saccaro, L. F., Busceti, C. L., Biagioni, F., & Fornai, F. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.009 · Cited by 80

Apolipoprotein E4 domain interaction: Synaptic and cognitive deficits in mice

Zhong, N., Scearce-Levie, K. A., Ramaswamy, G., & Weisgraber, K. H. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.01.006 · Cited by 77

An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia

Price, B. R., Norris, C. M., Sompol, P. M., & Wilcock, D. M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14273 · Cited by 76

Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-α treatment

Su, Z.-Z., Chen, Y., Kang, D., Chao, W., Simm, M., Volsky, D. J., & Fisher, P. B. (2003) · Gene · doi:10.1016/s0378-1119(03)00404-9 · Cited by 74

Aberrant Detergent-Insoluble Excitatory Amino Acid Transporter 2 Accumulates in Alzheimer Disease

Woltjer, R. L., Duerson, K. C., Fullmer, J. M., Mookherjee, P., Ryan, A. M., Montine, T. J., Kaye, J. A., Quinn, J. F., Silbert, L. C., Erten‐Lyons, D., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e24adb · Cited by 73

Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Aβ(1–42)☆

Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.09.024 · Cited by 72

Insensitivity of astrocytes to interleukin 10 signaling following peripheral immune challenge results in prolonged microglial activation in the aged brain

Norden, D. M., Trojanowski, P. J., Walker, F. R., & Godbout, J. P. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.014 · Cited by 73

A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease

Cioffi, F., Adam, R. H. I., Bansal, R., & Broersen, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210497 · Cited by 73

Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-κB

Rodriguez-Kern, A., Gegelashvili, M., Schousboe, A., Zhang, J., Sung, L., & Gegelashvili, G. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00023-8 · Cited by 72

The relationship between motor cortex excitability and severity of Alzheimer's disease: A transcranial magnetic stimulation study

Khedr, E. M., Ahmed, M. A., Darwish, E. S., & Ali, A. M. M. (2011) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2011.03.002 · Cited by 71

Altered expression of glutamate transporter‐1 and water channel protein aquaporin‐4 in human temporal cortex with Alzheimer's disease

Hoshi, A., Tsunoda, A., Yamamoto, T., Tada, M., Kakita, A., & Ugawa, Y. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12475 · Cited by 70

Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages

Poirel, O., Mella, S., Videau, C., Ramet, L., Davoli, M. A., Herzog, É., Katsel, P., Mechawar, N., Haroutunian, V. H., Epelbaum, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19154-y · Cited by 72

Glutamine Synthetase: Localization Dictates Outcome

Castegna, A., & Menga, A. (2018) · Genes · doi:10.3390/genes9020108 · Cited by 75

Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease

Smaga, I., Fierro, D., Mesa, J., Filip, M., & Knackstedt, L. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.016 · Cited by 69

Mechanisms of Amyloid β Protein-Induced Modification in Ion Transport Systems: Implications for Neurodegenerative Diseases

Kourie, J. I. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1010932603406 · Cited by 67

Impairments of glutamatergic synaptic transmission in Alzheimer’s disease

Zott, B., & Konnerth, A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.013 · Cited by 66

Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor

Sen, I., Nalini, A., Joshi, N. B., & Joshi, P. G. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.049 · Cited by 66

Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Protect against Neuronal Cell Death and Ameliorate Motor Deficits in Niemann Pick Type C1 Mice

Seo, Y., Yang, S., Jee, M. K., Joo, E. K., Roh, K.-H., Seo, M., Han, T. H., Lee, S. Y., Ryu, P. D., Jung, J., et al. (2011) · Cell Transplantation · doi:10.3727/096368910x545086 · Cited by 65

The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain

Fluteau, A., Ince, P. G., Minett, T., Matthews, F. E., Brayne, C., Garwood, C. J., Ratcliffe, L. E., Morgan, S., Heath, P. R., Shaw, P. J., et al. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.001 · Cited by 66

Reactive Astrocytes as Drug Target in Alzheimer’s Disease

Assefa, B. T., Gebre, A. K., & Altaye, B. M. (2018) · BioMed Research International · doi:10.1155/2018/4160247 · Cited by 66

Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease

Carter, S. F., Chiotis, K., Nordberg, A. K., & Rodriguez‐Vieitez, E. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4217-7 · Cited by 63

Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice

Osorio, C., Sullivan, P. M., Dong, H., Mace, B. E., Ervin, J. F., Strittmatter, W. J., & Álzate, Ó. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.011 · Cited by 62

Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice

Fan, S., Xian, X., Li, L., Yao, X., Hu, Y., Zhang, M., & Li, W. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180708 · Cited by 61

Advances and Challenges in Rational Drug Design for SLCs

Garibsingh, R. A., & Schlessinger, A. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.08.006 · Cited by 63

Region- and Activity-Dependent Regulation of Extracellular Glutamate

Pinky, N. F., Wilkie, C. M., Barnes, J. R., & Parsons, M. P. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3213-17.2018 · Cited by 60

Alternative splicing of the glutamate transporter EAAT2 (GLT-1)

Meyer, T., Münch, C., Knappenberger, B., Liebau, S., Völkel, H., & Ludolph, A. C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00973-7 · Cited by 58

The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains

Oka, A., & Takashima, S. (1999) · Acta Neuropathologica · doi:10.1007/s004010050985 · Cited by 57

Decrease in Glial Glutamate Transporter Variants and Excitatory Amino Acid Receptor Down-Regulation in a Murine Model of ALS-PDC

Wilson, J. M. B., Khabazian, I., Pow, D. V., Craig, U. K., & Shaw, C. A. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:105 · Cited by 57

Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies

Garcia‐Esparcia, P., Lucena, D. D., Ainciburu, M., Torrejón-Escribano, B., Carmona, M., Llorens, F., & Ferrer, I. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00122 · Cited by 56

Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease

Faculty, O. B. O. T. M., Boche, D., Gerhard, A., & Rodriguez-Vieitez, E. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04462-w · Cited by 55

Oxidative Stress: Glutathione and Its Potential to Protect Methionine-35 of Aβ Peptide from Oxidation

Mandal, P. K., Roy, R. G., & Samkaria, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c02760 · Cited by 56

Neurotrophic effects of Cerebrolysin® in animal models of excitotoxicity

Veinbergs, I., Mante, M., Mallory, M. E., & Masliah, E. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_29 · Cited by 53

Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?

Mather, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.013 · Cited by 57

Amyloid Protein Precursor Stimulates Excitatory Amino Acid Transport

Masliah, E., Raber, J., Alford, M. F., Mallory, M. E., Mattson, M. P., Yang, D., Wong, D. T., & Mucke, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12548 · Cited by 52

Good, bad, and neglectful: Astrocyte changes in neurodegenerative disease

Jiwaji, Z., & Hardingham, G. E. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.02.020 · Cited by 53

Rotenone Induces Cell Death of Cholinergic Neurons in an Organotypic Co-Culture Brain Slice Model

Ullrich, C., & Humpel, C. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0014-9 · Cited by 51

Glutamate, Glutamate Transporters, and Circadian Rhythm Sleep Disorders in Neurodegenerative Diseases

He, S., Zhang, X., & Qu, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00419 · Cited by 51

Reduced platelet glutamate uptake in Parkinson's disease

Ferrarese, C., Zoia, C., Pecora, N., Piolti, R., Frigo, M., Bianchi, G., Sala, G., Begni, B., Riva, R., & Frattola, L. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050189 · Cited by 51

Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease

Westphalen, R., Scott, H., & Dodd, P. (2003) · Journal of neural transmission · doi:10.1007/s00702-003-0012-z · Cited by 53

Elevated glutathione as a therapeutic strategy in Alzheimer's disease

Butterfield, D. A., Pocernich, C. B., & Drake, J. (2002) · Drug Development Research · doi:10.1002/ddr.10095 · Cited by 51

Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction

Kiryk, A., Aida, T., Tanaka, K., Banerjee, P., Wilczynski, G. M., Meyza, K. Z., Knapska, E., Filipkowski, R. K., Kaczmarek, L., & Danysz, W. (2008) · Neurotoxicity Research · doi:10.1007/bf03033364 · Cited by 50

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464

The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease

Tannenberg, R. K., Scott, H. L., Westphalen, R. I., & Dodd, P. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480591 · Cited by 37

Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains

Simpson, M. D. C., Royston, M. C., Deakin, J. F. W., Cross, A. J., Mann, D. M. A., & Slater, P. (1988) · Brain Research · doi:10.1016/0006-8993(88)90587-2 · Cited by 74

Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052193.x · Cited by 74

P3–199: The glutamate transporter, EAAT3 (EAAC1), is aberrantly expressed in hippocampus of individuals with Alzheimer's disease

Cook, D. G., Deurson, K., Leverenz, J. B., Bird, T. D., Montine, T. J., & Pow, D. V. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1467